Zobrazeno 1 - 10
of 1 092
pro vyhledávání: '"JONASOVA, A."'
Autor:
Anna Jonasova, Slavka Sotakova, Petra Belohlavkova, Lubomir Minarik, Tomas Stopka, Jan Jakub Jonas, Tatiana Aghova, Zuzana Zemanova
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundLuspatercept, an inhibitor of the transforming growth factor beta (TGF-β) pathway, is a novel treatment for anemic patients with lower-risk myelodysplastic syndromes (MDS) with transfusion dependence (TD) who do not respond to erythropoies
Externí odkaz:
https://doaj.org/article/247a1b3de16f41069ac9525bde74c80a
Autor:
Della Porta, Matteo Giovanni *, *, Garcia-Manero, Guillermo *, Santini, Valeria, Zeidan, Amer M, Komrokji, Rami S, Shortt, Jake, Valcárcel, David, Jonasova, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, Li, Jiahui, Zhang, Jennie, Pilot, Richard, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L, Rose, Shelonitda, Prebet, Thomas, Lai, Yinzhi, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Fenaux, Pierre †, Platzbecker, Uwe †
Publikováno v:
In The Lancet Haematology September 2024 11(9):e646-e658
Autor:
Iva Trsova, Andrea Hrustincova, Zdenek Krejcik, David Kundrat, Aleš Holoubek, Karolina Staflova, Lucie Janstova, Sarka Vanikova, Katarina Szikszai, Jiri Klema, Petr Rysavy, Monika Belickova, Monika Kaisrlikova, Jitka Vesela, Jaroslav Cermak, Anna Jonasova, Jiri Dostal, Jan Fric, Jan Musil, Michaela Dostalova Merkerova
Publikováno v:
Molecular Oncology, Vol 17, Iss 12, Pp 2565-2583 (2023)
Mutations in the splicing factor 3b subunit 1 (SF3B1) gene are frequent in myelodysplastic neoplasms (MDS). Because the splicing process is involved in the production of circular RNAs (circRNAs), we investigated the impact of SF3B1 mutations on circR
Externí odkaz:
https://doaj.org/article/cf124e1e1eda474f8d617a5629fc916b
Autor:
Platzbecker, Uwe *, *, Santini, Valeria *, Fenaux, Pierre, Sekeres, Mikkael A, Savona, Michael R, Madanat, Yazan F, Díez-Campelo, Maria, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Bělohlávková, Petra, Sherman, Laurie J, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, Komrokji, Rami S, Zeidan, Amer M
Publikováno v:
In The Lancet 20-26 January 2024 403(10423):249-260
Autor:
A. Jonasova, L. Minarik
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100444- (2024)
Introduction: Luspatercept is a recent breakthrough in the therapy of anemia in low-risk MDS. Methods: From January 2021 to October 2023, 44 patients (median age 77, M/F 25/19, WHO 2016 classification: MDS-RS-MLD 28, MDS-MLD -4, RARS-T 8, CMML- 0 2,
Externí odkaz:
https://doaj.org/article/8e13b25b51e242a095311dba09d187bd
Autor:
G. Garcia-Manero, U. Platzbecker, V. Santini, A. Zeidan, P. Fenaux, R. Komrokji, J. Shortt, D. Valcarcel, A. Jonasova, S. Dimicoli-Salazar, I.S. Tiong, C.-C. Lin, J. Li, J. Zhang, A.C. Giuseppi, S. Kreitz, V. Pozharskaya, K. Keeperman, S. Rose, T. Prebet, A. Degulys, S. Paolini, T. Cluzeau, M. Della Porta
Publikováno v:
Leukemia Research Reports, Vol 21, Iss , Pp 100447- (2024)
Introduction: We report the full analysis of the COMMANDS trial assessing efficacy and safety of luspatercept versus epoetin alfa (EA) in ESA-naive patients with LR-MDS. Methods: 363 patients (aged ≥18 y, with transfusion-dependent LR-MDS, serum er
Externí odkaz:
https://doaj.org/article/555def4973c34a6890e1d7c5f39d6456
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Platzbecker, Uwe *, *, Della Porta, Matteo Giovanni *, Santini, Valeria, Zeidan, Amer M, Komrokji, Rami S, Shortt, Jake, Valcarcel, David, Jonasova, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, Li, Jiahui, Zhang, Jennie, Giuseppi, Ana Carolina, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L, Rose, Shelonitda, Shetty, Jeevan K, Hayati, Sheida, Vodala, Sadanand, Prebet, Thomas, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Fenaux, Pierre †, Garcia-Manero, Guillermo †
Publikováno v:
In The Lancet 29 July-4 August 2023 402(10399):373-385
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jonasova, Anna, Sotakova, Slavka, Belohlavkova, Petra, Minarik, Lubomir, Stopka, Tomas, Jonas, Jan Jakub, Aghova, Tatiana, Zemanova, Zuzana
Publikováno v:
Frontiers in Oncology; 2024, p1-8, 8p